Aldosterone synthase deficiency and related disorders

Area of Science:

• Endocrinology
• Genetics
• Nephrology

Background:

• Aldosterone regulates intravascular volume and serum electrolytes (sodium, potassium) via the distal nephron.
• Inherited defects in aldosterone biosynthesis lead to hypovolemia, hyponatremia, and hyperkalemia.
• These defects arise from 21-hydroxylase (CYP21) deficiency affecting cortisol, or isolated aldosterone synthase (CYP11B2) deficiency.

Purpose of the Study:

• To summarize the causes and consequences of inherited defects in aldosterone biosynthesis.
• To highlight the genetic basis of conditions leading to hypoaldosteronism.
• To discuss the diagnostic criteria and clinical presentation of these disorders.

Main Methods:

• Review of genetic mutations in CYP21 and CYP11B2 genes.
• Analysis of clinical phenotypes associated with impaired aldosterone synthesis.
• Comparison of aldosterone biosynthesis defects with familial hyperreninemic hypoaldosteronism.

Main Results:

• Enzymatic activity typically needs to be <1% of normal for aldosterone biosynthesis impairment.
• Mutations in CYP21 affect both cortisol and aldosterone production.
• A subset of familial hyperreninemic hypoaldosteronism lacks CYP11B2 mutations, indicating other genetic causes.

Conclusions:

• Inherited defects in aldosterone biosynthesis have significant clinical consequences.
• Genetic testing is crucial for diagnosing CYP21 and CYP11B2 deficiencies.
• Further research is needed to identify the genetic basis of familial hyperreninemic hypoaldosteronism not linked to CYP11B2.